SERS for Point-of-Care and Clinical Applications 2022
DOI: 10.1016/b978-0-12-820548-8.00003-5
|View full text |Cite
|
Sign up to set email alerts
|

In vivo imaging with SERS nanoprobes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 137 publications
0
3
0
Order By: Relevance
“…6 SERS nanoparticles have been reported in preclinical studies to accumulate in tumors via passive targeting and to bind specific molecular targets when functionalized with antibodies or other targeting moieties. 5,7 As shown in Figure 1, SERS nanoparticles are typically composed of a gold core decorated with a Raman reporter molecule and encapsulated within a silica shell. Star-shaped nanoparticles have plasmonic resonance in the near-infrared (IR), enabling imaging with a 785 nm laser.…”
Section: Introductionmentioning
confidence: 99%
“…6 SERS nanoparticles have been reported in preclinical studies to accumulate in tumors via passive targeting and to bind specific molecular targets when functionalized with antibodies or other targeting moieties. 5,7 As shown in Figure 1, SERS nanoparticles are typically composed of a gold core decorated with a Raman reporter molecule and encapsulated within a silica shell. Star-shaped nanoparticles have plasmonic resonance in the near-infrared (IR), enabling imaging with a 785 nm laser.…”
Section: Introductionmentioning
confidence: 99%
“…5 Nanovehicles provide an innovative method of drug transport that offers protection from degradation, increases drug solubility, extends circulation time, delays drug clearance, and enhances tumor access via the enhanced permeability and retention (EPR) effect. 6,7…”
Section: Introductionmentioning
confidence: 99%
“…5 Nanovehicles provide an innovative method of drug transport that offers protection from degradation, increases drug solubility, extends circulation time, delays drug clearance, and enhances tumor access via the enhanced permeability and retention (EPR) effect. 6,7 Polymeric nanoparticles have gained attention as cancer drug delivery vehicles due to their unique structural features but also due to the biocompatibility and biodegradability exhibited by the constituent polymers. 8 Amphiphilic polymers in aqueous solutions self-assemble into micellar structures with a hydrophilic shell and a hydrophobic core.…”
Section: Introductionmentioning
confidence: 99%